CURALEAF HLDGS INC by Curaleaf Holdings, Inc. Analyst Price Targets - Benzinga

CURALEAF HLDGS INC by Curaleaf Holdings, Inc.

CURLFOTCQX

Trade with Public

Trade with Public

$8.48

-0.01-0.12%

Ult. Agg.: Oct 19, 8:25 AM

Panoramica Notizie Previsioni utiliObiettivi di prezzoDati finanziari Sentiment Confronta

© 2026 Benzinga | All Rights Reserved

CURALEAF HLDGS INC by Curaleaf Holdings, Inc. Analyst Price Targets - Benzinga

CURALEAF HLDGS INC by Curaleaf Holdings, Inc. Analyst Price Targets

Wall Street analyst price targets and consensus rating for CURALEAF HLDGS INC by Curaleaf Holdings, Inc. (CURLF).

Price Target Range — 3 Quarters

Analyst Consensus — 3 Analysts

2Buy

1Hold

Consensus RatingHold# Analysts3Avg. Consensus PT$16Upside to Avg. PT+101.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 8, 2024	Needham	Matt McGinley	Maintained	Buy	$19
May 10, 2024	Needham	Matt McGinley	PT Raise	Buy	$16→$19
Mar 8, 2024	Wedbush	Gerald Pascarelli	PT Raise	Outperform	$14→$18
Mar 7, 2024	Craig-Hallum	Eric Des Lauriers	PT Raise	Hold	$8→$11
Mar 7, 2024	Needham	Matt McGinley	PT Raise	Buy	$13→$16

Analyst Ratings News

This Week In Cannabis: Gaetz's Stock Rally, Major Policy Battles, Homeland Security's Stance, Big Earnings And More

Cannabis news this week: Gaetz sparks cannabis stock rally, Homeland Security reaffirms seizures, key policy moves and major earnings shake the industry.

Javier Hasse

The Price Is Right: This Weed Real Estate Stock Proves Conservative Strategies Bring Returns

New Lake Capital Partners (OTC:NLCP), a real estate company focused on cannabis properties, offers an attractive investment with a 9.1% dividend yield, well above the return on 10-year government bonds.

Nicolás Jose Rodriguez

Europe Says Thanks But We'll Do It Ourselves - Canada Leads In Raw Cannabis Exports, Not Oil

While dried flower exports have flourished, the growth of Canada's cannabis extracts, including oils and vapes, has been more erratic.

Nicolás Jose Rodriguez

Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?

For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance.

Nicolás Jose Rodriguez

Diversify Around And Find Out: Can Vegas Superstore And Florida Sales Boost This Weed Penny Stock?

Is this 40-cent cannabis stock undervalued? Zuanic & Associates dives into its growth potential and market prospects.

Nicolás Jose Rodriguez

80% Leverage, 5.5x EBITDA: Is Cresco The High-Risk, High-Reward Play Investors Need?

According to Z&A, its enterprise value (EV) to current sales ratio stands at 1.6x, lower than Curaleaf and Green Thumb, both at 2.2x.

Nicolás Jose Rodriguez